Protein folding and misfolding: A paradigm of self-assembly and regulation in complex biological systems

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 361, Issue 1807, 2003, Pages 1205-1222

  Vendruscolo, Michele ^a   Zurdo, Jesús ^a   Macphee, Cait E ^b   Dobson, Christopher M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Biological complexity; Biological evolution; Misfolding diseases; Nanotechnology; Protein folding; Self organization

Indexed keywords

PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CHEMISTRY; FEEDBACK SYSTEM; HUMAN; MACROMOLECULE; METABOLISM; MOLECULAR EVOLUTION; PARKINSON DISEASE; PHYSIOLOGY; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE;

ALZHEIMER DISEASE; EVOLUTION, MOLECULAR; FEEDBACK, BIOCHEMICAL; HUMANS; MACROMOLECULAR SUBSTANCES; PARKINSON DISEASE; PRION DISEASES; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS;

EID: 0043236283     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2003.1194     Document Type: Conference Paper

References (65)

1. Alon, U., Surette, M. G., Barkai, N. & Leibler, S. 1999 Robustness in bacterial chemotaxis. Nature 397, 168-171.
2. Anfinsen, C. B. 1973 Principles that govern the folding of protein chains. Science 181, 223-230.
3. Baumeister, W. & Steven, A. C. 2000 Macromolecular electron microscopy in the era of structural genomics. Trends Biochem. Sci, 25, 624-631.
4. Bolon, D. N. & Mayo, S. L. 2001 Enzyme-like proteins by computational design. Proc. Natl Acad. Sci. USA 98, 14274-14279.
5. Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Eraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E. & Blake, C. C. F. 1997 Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787-793.
6. Brooks, C. L., Onuchic, J. N. & Wales, D. J. 2001 Statistical thermodynamics: taking a walk on a landscape. Science 293, 612-613.
7. Broome, B. M. & Hecht, M. H. 2000 Nature disfavors sequences of alternating polar and nonpolar amino acids: implications for amyloidogenesis. J. Mol. Biol 296, 961-968.
8. Bryngelson, J. D., Onuchic, J. N., Socci, N. D. & Wolynes, P. G. 1995 Funnels, pathways, and the energy landscape of protein-folding: a synthesis. Proteins Struct. Funct. Genet. 21, 167-195.
9. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J. S., Taddei, N., Ramponi, G., Dobson, C. M. & Stefani, M. 2002 Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
10. Bullock, A. & Fersht, A. R. 2001 Rescuing the function of mutant p53. Nat. Rev. Cancer 1, 68-76.
11. Carlson, J. M. & Doyle, J. 2002 Complexity and robustness. Proc. Natl Acad. Sci. USA 99, 2538-2545.
12. Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M., Normark, S. & Hultgren, S. J. 2002 Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851-855.
13. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G. & Dobson, C. M. 1999 Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96, 3590-3594.
14. Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G. & Dobson, C. M. 2002 Kinetic partitioning of protein folding and aggregation. Nature Struct. Biol. 9, 137-143.
15. Csete, M. E. & Doyle, J. C. 2002 Reverse engineering of biological complexity. Science 295, 1664-1669.
16. Dinner, A. R., Sali, A., Smith, L. J., Dobson, C. M. & Karplus, M. 2000 Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 25, 331- 339.
17. Dobson, C. M. 1999 Protein misfolding, evolution and disease. Trends Biochem. Sci. 24, 329- 332.
18. Dobson, C. M. 2001 The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356, 133-145.
19. Dobson, C. M. 2002 Protein-misfolding diseases: getting out of shape. Nature 418, 729-730.
20. Drexler, K. E. 1999 Building molecular machine systems. Trends. Biotechnol. 17, 5-7.
21. Duan, Y. & Kollman, P. A. 1998 Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution. Science 282, 740-744.
22. Edelman, G. M. & Gaily, J. A. 2001 Degeneracy and complexity in biological systems. Proc. Natl Acad. Sci. USA 98, 13763-13768.
23. Ellis, R. J. 2001 Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr. Opin. Struct. Biol. 11, 114-119.
24. Fersht, A. R. & Daggett, V. 2002 Protein folding and unfolding at atomic resolution. Cell 108, 573-582.
25. Gavin, A. C., Bosche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A. M. & Cruciat, C. M. 2002 Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-147.
26. Goldenfeld, N. & Kadanoff, L. P. 1999 Simple lessons from complexity. Science 284, 87-89.
27. Gsponer, J., Haberthur, U. & Caflisch, A. 2003 The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35. Proc. Natl Acad. Sci. USA 100, 5154-5159.
28. Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D. & Dobson, C. M. 1998 Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA 95, 4224-4228.
29. Hartwell, L. H., Hopfield, J. J., Leibler, S. & Murray, A. W. 1999 From molecular to modular cell biology. Nature 402, C47-C52.
30. Hasty, J., McMillen, D., Isaacs, F. & Collins, J. J. 2001 Computational studies of gene regulatory networks: in numero molecular biology. Nat. Rev. Genet. 2, 268-279.
31. Hecht, M. H., Richardson, J. S., Richardson, D. C. & Ogden, R. C. 1990 De novo design, expression, and characterization of Felix: a 4-helix bundle protein of native-like sequence. Science 249, 884-891.
32. Jimenez, J. L., Guijarro, J. L., Orlova, E., Zurdo, J., Dobson, C. M., Sunde, M. & Saibil, H. R. 1999 Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18, 815-821.
33. Kelly, J. W. 1998 The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8, 101-106.
34. Kitano, H. 2002 Computational system biology. Nature 420, 206-210.
35. Klein-Seetharaman, J., Oikawa, M., Grimshaw, S. B., Winner, J., Duchardt, E., Ueda, T., Imoto, T., Smith, L. J., Dobson, C. M. & Schwalbe, H. 2002 Long-range interactions within a nonnative protein. Science 295, 1719-1722.
36. Lander, E. S. and International Human Genome Sequencing Consortium 2001 Initial sequencing and analysis of the human genome. Nature 409, 860-921.
37. Levine, B. L. (and 12 others) 2002 Adoptive transfer of co-stimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nature Med. 8, 47-53.
38. Lowe, C. R. 2000 Nanobiotechnology: the fabrication and applications of chemical and biological nanostructures. Curr. Opin. Struct. Biol. 10, 428-434.
39. MacPhee, C. E. & Dobson, C. M. 2000 Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. J. Am. Chem. Soc. 122, 12707-12713.
40. Matouschek, A., Kellis, J. T., Serrano, L., Bycroft, M. & Fersht, A. R. 1990 Transient folding intermediates characterized by protein engineering. Nature 346, 440-445.
41. Middelberg, A. R. 2002 Preparative protein refolding. Trends. Biotechnol. 20, 437-443.
42. Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D. & Alon, U. 2002 Network motifs: simple building blocks of complex networks. Science 298, 824-827.
43. Nurse, P. 2000 A long twentieth century of the cell cycle and beyond. Cell 100, 71-78.
44. Oltvai, Z. N. & Barabasi, A. L. 2002 Life's complexity pyramid. Science 298, 763-764.
45. Prusiner, S. B. 1997 Prion diseases and the BSE crisis. Science 278, 245-251.
46. Radford, S. E. & Dobson, C. M. 1999 From computer simulations to human disease: emerging themes in protein folding. Cell 97, 291-298.
47. Richardson, J. S. & Richardson, D. C. 2002 Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl Acad. Sci. USA 99, 2754-2759.
48. Rumbley, J., Hoang, L., Mayne, L. & Englander, S. W. 2001 An amino acid code for protein folding. Proc. Natl Acad. Sci. USA 98, 105-112.
49. Sacchettini, J. C. & Kelly, J. W. 2002 Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Disc. 1, 267-275.
50. Selkoe, D. J. 2002 Alzheimer's disease is a synaptic failure. Science 298, 789-791.
51. Shakhnovich, E., Abkevich, V. & Ptitsyn, O. 1996 Conserved residues and the mechanism of protein folding. Nature 379, 96-98.
52. Simpson, M. L., Sayler, G. S., Fleming, J. T. V Applegate, B. 2001 Whole-cell biocomputing. Trends. Biotechnol. 19, 317-323.
53. Svensson, M., Hakansson, A., Mossberg, A. K., Linse, S. & Svanborg, C. 2000 Conversion of alpha-lactalbumin to a protein-inducing apoptosis. Proc. Natl Acad. Sci. USA 97, 4221-4226.
54. Tahiri-Alaoui, A., Bouchard, M., Zurdo, J. & James, W. 2003 Competing intrachain interactions regulate the formation of β-sheet fibrils in bovine PrP peptides. Protein Sci. 12, 600-608.
55. True, H. L. & Lindquist, S. L. 2000 A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407, 477-483.
56. Vendruscolo, M., Paci, E., Dobson, C. M. & Karplus, M. 2001 Three key residues from a critical contact network in a protein folding transition state. Nature 409, 641-645.
57. Venter, J. C. et al. 2001 The sequence of the human genome. Science 291, 1304-1351.
58. Villegas, V., Zurdo, J., Filimov, V. V., Aviles, F. X., Dobson, C. M & Serrano, L. 2000 Protein engineering as a strategy to avoid formation of anyloid fibrils. Protein Sci. 9, 1700-1708.
59. Walsh, C. 2000 Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775-781.
60. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J. & Selkoe, D. J. 2002 Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
61. Wang, W. X. & Hecht, M. H. 2002 Rationally designed mutations convert de novo amyloid-like fibrils into monomeric beta-sheet proteins. Proc. Natl Acad. Sci. USA 99, 2760-2765.
62. Waterston, R. H., Lander, E. S. & Sulston, J. E. 2002 On the sequencing of the human genome. Proc. Natl Acad. Sci. USA 99, 3712-3716.
63. Weng, G. Z., Bhalla, U. S. & Iyengar, R. 1999 Complexity in biological signaling systems. Science 284, 92-96.
64. Worth-Matravers, P., Bridgeman, J. & Ferguson-Smith, M. 2000 The BSE inquiry. London: The Stationery Office.
65. Yeates, T. O. & Padilla, J. E. 2002 Designing supramolecular protein assemblies. Curr. Opin. Struct. Biol. 12, 464-470.